20-18427071-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001367614.1(DZANK1):c.1007A>T(p.Gln336Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000171 in 1,609,308 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001367614.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DZANK1 | NM_001367614.1 | c.1007A>T | p.Gln336Leu | missense_variant | 10/21 | ENST00000699568.1 | NP_001354543.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DZANK1 | ENST00000699568.1 | c.1007A>T | p.Gln336Leu | missense_variant | 10/21 | NM_001367614.1 | ENSP00000514442 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000887 AC: 22AN: 248040Hom.: 0 AF XY: 0.0000892 AC XY: 12AN XY: 134564
GnomAD4 exome AF: 0.000176 AC: 256AN: 1457040Hom.: 0 Cov.: 29 AF XY: 0.000182 AC XY: 132AN XY: 724694
GnomAD4 genome AF: 0.000125 AC: 19AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74452
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.950A>T (p.Q317L) alteration is located in exon 10 (coding exon 9) of the DZANK1 gene. This alteration results from a A to T substitution at nucleotide position 950, causing the glutamine (Q) at amino acid position 317 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at